98%
921
2 minutes
20
Background: Transcatheter aortic valve implantation-in-transcatheter aortic valve implantation represents a progressive solution for patients with degenerated transcatheter heart valves, especially those at high surgical risk. With the increasing use of transcatheter aortic valve implantation worldwide, the need for redo procedures is also rising. Balloon-expandable valves such as the Myval transcatheter heart valve (Meril Life Sciences Pvt. Ltd.) offer design advantages of enhanced radial strength, low-profile frames, and effective sealing, making them suitable for complex valve-in-valve scenarios. An essential procedural concern in redo transcatheter aortic valve implantation is the risk of coronary obstruction, particularly involving the left main coronary artery, requiring pre-emptive planning strategies such as the chimney technique.
Case Presentation: We report the case of a 68-year-old female patient of Indian ethnicity with prior transcatheter aortic valve implantation using a 26 mm CoreValve (Medtronic), presenting with symptomatic valve degeneration. Her case having been deemed high-risk for open surgical intervention, she was selected for a transcatheter aortic valve implantation-in-transcatheter aortic valve implantation procedure. Preprocedural computed tomography imaging showed a critical risk plane for the left main coronary artery, necessitating coronary protection. A 23 mm balloon-expandable Myval transcatheter heart valve was implanted using transfemoral access. Coronary protection was initiated with prepositioning of a coronary guidewire in the left coronary artery. Following valve deployment, the patient developed hypotension with left main coronary artery flow compromise, requiring bailout left main coronary artery stenting, resulting in a chimney configuration. Postdeployment angiography confirmed optimal valve positioning with preserved coronary flow. The patient initially developed hypotension and severe hypokinesia, which was managed successfully with emergency left main coronary artery stenting and supportive care. She exhibited immediate hemodynamic recovery and was discharged in a stable condition. This is the first documented case of a Myval-based transcatheter aortic valve implantation-in-transcatheter aortic valve implantation with left main coronary artery chimney stenting from East India.
Conclusion: This case highlights the feasibility, safety, and procedural effectiveness of the Myval balloon-expandable transcatheter heart valve in a redo transcatheter aortic valve implantation setting. It also underscores the importance of anatomical evaluation, risk stratification, and pre-emptive coronary protection in complex structural heart interventions. The successful use of the chimney technique reinforces its role in mitigating life-threatening coronary occlusion during valve-in-valve procedures. This report contributes to the growing evidence supporting the use of next-generation transcatheter heart valves for complex redo transcatheter aortic valve implantation scenarios and expands the clinical applicability of Myval in high-risk cases.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323054 | PMC |
http://dx.doi.org/10.1186/s13256-025-05471-0 | DOI Listing |
Arq Bras Cardiol
September 2025
Escola Bahiana de Medicina e Saúde Pública, Salvador, BA - Brasil.
Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.
Objective: To determine the risk factors for valvular calcification in patients with CKD.
J Invasive Cardiol
September 2025
Department of Cardiology, Zhongshan Hospital, Fudan University, National Clinical Research Center for Interventional Medicine, Shanghai, China. Email:
J Invasive Cardiol
September 2025
Cardiac Surgery Unit, Mediterranea Cardiocentro, Naples, Italy.
Objectives: Failure of vascular closure device (VCD) is the most common cause of access-site vascular complications in transfemoral transcatheter aortic valve implantation (TAVI). The authors sought to determine if the systematic use of arteriotomy-site ballooning with concomitant manual compression following the delivery of a plug-based VCD (MANTA, Teleflex) can optimize toggle-plug assembly apposition to the common femoral artery (CFA) wall and improve the final hemostatic efficacy.
Methods: In this prospective, observational, single-center study, 323 consecutive patients undergoing transfemoral TAVI from October 2021 to December 2024 underwent access closure with the MANTA VCD.
J Invasive Cardiol
September 2025
Newark Beth Israel Medical Center, Newark, New Jersey.
Objectives: The authors hypothesized that the origin of the right coronary artery (RCA) is a direct continuation of the major aortic arch branches (MAAB) takeoff plane, which may have implications for brachiocephalic interventions and next generation transcatheter aortic valve intervention (TAVI) embolic protection devices (EPDs).
Methods: In this single-center, retrospective, cross-sectional study, the authors analyzed computed tomographic angiography (CTA) images from 92 patients undergoing TAVI evaluation to determine the spatial relationship between the origin of the RCA and the MAAB takeoff plane. Patients with prior cardiothoracic or aortic interventions and those with anomalous RCA origin were excluded.
Int J Surg
September 2025
Department of Cardiovascular Surgery, The Affiliated Hospital, Southwest Medical University, Metabolic Vascular Diseases Key Laboratory of Sichuan Province, Key Laboratory of Cardiovascular Remodeling and Dysfunction, Luzhou, Sichuan, PR China.
Objective: This meta-analysis aimed to compare the perioperative safety and efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in bicuspid aortic valve (BAV) stenosis.
Methods: We systematically analyzed studies from PubMed, Cochrane Library, Embase, and CNKI comparing TAVR and SAVR in BAV stenosis. Outcomes included postoperative mortality, complications, all-cause survival, and freedom from stroke.